# Malonyl-CoA Decarboxylase: A Spotlight on Brain Aspects

**Authors:** Monique Fonseca-Teixeira, Elaine Silva Brito, Clara Beltrao-Valente, Bruna Klippel Ferreira, Patricia Fernanda Schuck, Gustavo Costa Ferreira

PMC · DOI: 10.3390/brainsci16020220 · Brain Sciences · 2026-02-12

## TL;DR

This paper explores the role of the enzyme MCD in the brain, focusing on its regulation, function, and potential as a target for treating metabolic disorders.

## Contribution

The paper highlights current gaps in understanding MCD's role in brain metabolism and its potential therapeutic implications.

## Key findings

- MCD expression in the brain varies during development and is influenced by nutritional states.
- Inherited MCD deficiency causes malonic acid accumulation and primarily affects the central nervous system.
- Pharmacological modulation of MCD shows potential in treating obesity, diabetes, and ischemic injury.

## Abstract

Malonyl-CoA decarboxylase (MCD) is an enzyme that controls malonyl-CoA levels and regulates fatty acid synthesis and oxidation. Although its physiological relevance in peripheral tissues is well known, the role of MCD in the central nervous system remains poorly understood. MCD is expressed in mitochondria, cytosol, and peroxisomes and may be regulated by PPAR-α, AMPK, and SIRT4 in tissues such as muscle, liver and kidney. In the brain, MCD expression varies during development and can respond to nutritional states. Inherited MCD deficiency (malonic aciduria) leads to the toxic accumulation of malonic acid and predominantly affects the central nervous system. The underlying mechanisms leading to brain damage in MCD patients remain unclear. Conversely, pharmacological modulation of MCD activity has been studied in obesity, diabetes, and ischemic injury, highlighting its therapeutic potential. There are still major gaps regarding MCD cellular distribution, regulatory pathways, and metabolic interaction with CPT1c (carnitine palmitoyltransferase 1c) in neural metabolism. A deeper understanding of the role of MCD in brain physiology and pathology may indicate novel therapeutic strategies targeting metabolic disorders that involve altered malonyl-CoA dynamics. Here, we discuss the current knowns and unknowns regarding MCD physiology, regulation, and pathophysiology, emphasizing brain aspects.

## Linked entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582]
- **Proteins:** MUC1 (mucin 1, cell surface associated), PPARA (peroxisome proliferator activated receptor alpha), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), SIRT4 (sirtuin 4), CPT1C (carnitine palmitoyltransferase 1C)
- **Chemicals:** malonyl-CoA (PubChem CID 644066), malonic acid (PubChem CID 867)
- **Diseases:** malonic aciduria (MONDO:0009556)

## Full-text entities

- **Genes:** MLYCD (malonyl-CoA decarboxylase) [NCBI Gene 23417] {aka MCD}, ACSF3 (acyl-CoA synthetase family member 3) [NCBI Gene 197322], Cpt1c (carnitine palmitoyltransferase 1c) [NCBI Gene 78070] {aka 6530437J22Rik, 9630004I06Rik, CPT I-C, CPT IC, CPT1-B, CPTI-B}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376] {aka CPT1, CPTASE, IIAE4}, Mlycd (malonyl-CoA decarboxylase) [NCBI Gene 85239] {aka Mcd}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, SLC25A10 (solute carrier family 25 member 10) [NCBI Gene 1468] {aka DIC, MTDPS19}, Sacm1l (SAC1 suppressor of actin mutations 1-like (yeast)) [NCBI Gene 83493] {aka SAC1, Sac1p, mKIAA0851}, Mlycd (malonyl-CoA decarboxylase) [NCBI Gene 56690] {aka Mcd}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, ACACB (acetyl-CoA carboxylase beta) [NCBI Gene 32] {aka ACACbeta, ACC-beta, ACC2, ACCB, ACCbeta, HACC275}, SDHB (succinate dehydrogenase complex iron sulfur subunit B) [NCBI Gene 6390] {aka CWS2, IP, MC2DN4, PGL4, PPGL4, SDH}, CPT1B (carnitine palmitoyltransferase 1B) [NCBI Gene 1375] {aka CPT1-M, CPT1M, CPTI, CPTI-M, M-CPT1, MCCPT1}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, SIRT4 (sirtuin 4) [NCBI Gene 23409] {aka SIR2L4}, CPT1C (carnitine palmitoyltransferase 1C) [NCBI Gene 126129] {aka CATL1, CPT I-C, CPT1-B, CPT1P, CPTI-B, CPTIC}, RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, ACOT7 (acyl-CoA thioesterase 7) [NCBI Gene 11332] {aka ACH1, ACT, BACH, CTE-II, LACH, LACH1}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}
- **Diseases:** neuropathological (MESH:D009422), genetic metabolic diseases (MESH:D008659), seizures (MESH:D012640), cardiomyopathy (MESH:D009202), cortical malformation (MESH:D054220), cardiac dysfunction (MESH:D006331), IEM (MESH:D008661), weight gain (MESH:D015430), white matter abnormalities (MESH:D056784), language and psychomotor impairment (MESH:D007806), obesity (MESH:D009765), MCD Deficiency (MESH:C535702), language and psychomotor delay (MESH:D007805), insulin resistance (MESH:D007333), neuroinflammation (MESH:D000090862), brain atrophy (MESH:C566985), sudden death (MESH:D003645), neurodevelopmental delay (MESH:D006968), ischemic injury (MESH:D017202), ischemic (MESH:D002545), diabetes (MESH:D003920), neurological damage (MESH:D020196), intellectual disability (MESH:D008607), brain damage (MESH:D001925), growth retardation (MESH:D006130), mitochondrial dysfunction (MESH:D028361), injury to (MESH:D014947), neurodegenerative diseases (MESH:D019636), inflammation (MESH:D007249), hypotonia (MESH:D009123)
- **Chemicals:** Glucose (MESH:D005947), dicarboxylic acids (MESH:D003998), Ketone bodies (MESH:D007657), blood glucose (MESH:D001786), reactive oxygen species (MESH:D017382), ceramide (MESH:D002518), sphingolipids (MESH:D013107), lipopolysaccharide (MESH:D008070), free fatty acids (MESH:D005230), Lipids (MESH:D008055), Acetyl-CoA (MESH:D000105), Malonyl-CoA (MESH:D008316), ATP (MESH:D000255), triglyceride (MESH:D014280), essential fatty acid (MESH:D005228), TCA (MESH:D014238), CoA (MESH:D003065), acylcarnitine (MESH:C116917), tricarboxylic acid (MESH:D014233), carbon (MESH:D002244), Fatty acid (MESH:D005227), lactate (MESH:D019344), acyl-CoA (MESH:D000214), unsaturated fatty acids (MESH:D005231), L-carnitine (MESH:D002331), oxygen (MESH:D010100), Malonate (MESH:C030290), Fatty acylcarnitine (-)
- **Species:** Bombyx mori (domestic silkworm, species) [taxon 7091], Anser sp. (goose, species) [taxon 8847], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938996/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938996/full.md

## References

156 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938996/full.md

---
Source: https://tomesphere.com/paper/PMC12938996